$26.4 Billion Amgen Buyout Sends Horizon Stock Soaring

The stock is headed back toward its annual highs

Digital Content Manager
Dec 12, 2022 at 9:36 AM
facebook twitter linkedin

The shares of Horizon Therapeutics PLC (NASDAQ:HZNP) are up 14.9% at $111.75 this morning, following reports that Amgen (AMGN) will buy the biopharmaceutical company in a deal worth roughly $26.4 billion. The deal will give each Horizon shareholder $116.50 per share for each share owned, and will likely close in the first half f 2023, according to one Amgen executive. 

HZNP blew past recent pressure at the 170-day moving average late last month. Today's pop is set to put the security much closer to its 2022 high of $117.49, and could help the stock erase its 9.7% year-to-date deficit. 

An unwinding of pessimism among options traders could push HZNP even higher. The equity's Schaeffer's put/call open interest ratio (SOIR) of 1.52 stands higher than 98% of readings from the past year. In other words, short-term options traders have rarely been more put-biased. 

Echoing this, 2.13 puts have been picked up for every call at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio stands higher than 77% of readings from the past year, meaning there's been an unusually healthy appetite for puts of late. 


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!